Source - LSE Regulatory
RNS Number : 3739O
Compagnie de Saint-Gobain
02 December 2024
SAINT-GOBAIN closes its divestment of pam building,
its sanitary and rainwater drainage PIPE business
Saint-Gobain has finalized on November 29, 2024 its divestment of PAM Building, its pipes subsidiary dedicated to the manufacturing of sanitary and rainwater drainage solutions for buildings, to Aldebaran (a French institutional investment fund) with a minority stake from Bpifrance (the French Public Investment Bank).
PAM Building has two production plants, in Bayard (Haute-Marne, France) and in Telford (United Kingdom), employs 400 people and generated revenues of around €110 million in 2023.
This divestment project is part of Saint-Gobain's continued business profile optimization strategy, in line with its "Grow & Impact" plan.
About Saint-Gobain
Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group's commitment is guided by its purpose, "MAKING THE WORLD A BETTER HOME".
€47.9 billion in sales in 2023
160,000 employees, locations in 76 countries
Committed to achieving net zero carbon emissions by 2050
For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain
| Analyst/investor relations | Press relations | |||
| Vivien Dardel: | +33 1 88 54 29 77 | Patricia Marie: | +33 1 88 54 26 83 | |
| Floriana Michalowska: | +33 1 88 54 19 09 | Laure Bencheikh: | +33 1 88 54 26 38 | |
| Alix Sicaud: | +33 1 88 54 38 70 | Yanice Biyogo: | +33 1 88 54 27 96 | |
| James Weston: | +33 1 88 54 01 24 |
|
| |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
